Podcast: Building And Scaling Your Workforce: The Importance Of A Flexible Delivery Model In 2024 & Beyond

Generate a summary of this article
Listen to this article
Beta
  

Talent acquisition plays a central role in fostering creativity and innovation within any organization. In today’s highly competitive and fast-moving life sciences sector, it’s more important than ever. Tune into this free podcast to gain valuable insights on maintaining a competitive edge through innovative recruitment and retention strategies.

Listen now, and explore topics including:

  • The importance of organizational culture, flexible working, a diverse leadership and meaningful work when identifying and retaining talent
  • The current skills gaps in the sector
  • Operational challenges facing life sciences looking to scale on a global level, and the critical role of a flexible staffing model
  • Key considerations when scaling your workforce
  • Balancing scientific and technological expertise in recruitment
  • The impact of emerging technologies, such as gene editing, personalized medicines and AI on talent acquisition
  • Reflections on 2023, and tips for revolutionizing the talent ecosystem in 2025

Citeline · Building And Scaling Your Workforce: The Importance Of A Flexible Delivery Model In 2024 & Beyond

Open Media

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Leadership

ProGen’s Dual Agonist Obesity Contender Gains Momentum With Rani Partnership

 
• By Jung Won Shin

The CEO of South Korean biotech shares how his company was able to reach a partnership with Rani so quickly and why it is confident in its GLP-1/GLP-2 dual agonist for obesity and diabetes, despite recent disappointing clinical results for its sole rival.

Scrip-Leadership (Free-2): Titans Of Pharma: Lilly’s Ricks Tops Big Pharma Pay Chart

 
• By Nabil

The big pharma CEO with the highest-valued compensation in 2024 was David Ricks of Eli Lilly, while Pfizer and J&J executives slipped into third and fourth place behind AbbVie's now retired chief Richard Gonzalez. European firms brought up the rear.

As More DLL3 Bispecifics Advance, Doctors Are Adjusting To CRS, ICANS

 
• By Mandy Jackson

Amgen’s Imdelltra for small-cell lung cancer is one of two bispecific T-cell engagers approved for solid tumors, but data at the WCLC meeting show other DLL3-targeting BiTEs may be on the way.

Novo Nordisk’s Semaglutide Shows Promise In Hidradenitis Suppurativa

 
• By Andrew McConaghie

An academic study of GLP-1 agonist showed promise in patients with the painful skin condition but with no signs that the Danish drugmaker will pursue the indication, smaller players in the space may be interested.

More from Scrip

Sponsored by :

Clinical Trial Complexity Is Reshaping Evidence Collection Clinical trial innovation has historical - Clone

As clinical trials grow more complex, execution pressures are changing where and how evidence is collected.

Sponsored by :

Clinical Trial Complexity Is Reshaping Evidence Collection Clinical trial innovation has historical

As clinical trials grow more complex, execution pressures are changing where and how evidence is collected.

Primal Pictures

GB-Business-Free: ‘Content’ article that includes different Composer content published on 4 Dec after the BIOME redeployment...

To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.